Europe Immunohematology Market to Cross $ 442 Mn by 2024

March 06, 2020


The research report titled ‘Europe Immunohematology Market Size By Product, Technology, End-use, Industry Analysis Report, Regional Outlook, End-use Potential, Competitive Market Share & Forecast, 2018 – 2024’, which is available at MarketStudyReport.com, highlights the growth trends and the commercialization matrix of Europe immunohematology market.
 

According to the report, Europe immunohematology market is expected to surpass USD 442 million by the year 2024. Factors such as increased pervasiveness of hematology disorders such as sickle-cell, thalassemia, and leukemia are majorly driving the market growth. Thalassemia is a type of inherited blood ailment that lowers hemoglobin production. Patients suffering from such disorder require recurrent blood transfusions, thereby facilitating Europe immunohematology market expansion.
 

Advancements in technology pertaining to immunohematology analyzers are stimulating the industry outlook. These advanced systems are used in applications such as cross-matching, identification, donor antibody screening, phenotyping, antibody screening, and grouping. Thus, shifting focus towards R&D activities among key industry players to develop fully automated high-throughput devices is fostering the demand for the product across Europe. However, strict regulations and pre-defined standards for immunohematology devices may hinder the market growth.
 

By product, the report states that reagents market segment held 65% share in the year 2017 is expected to register significant growth by the year 2024. Rising prevalence of hematological disorders have impelled the demand for recurring blood testing devices. Moreover, reagents are widely preferred in diagnostic centers owing to their high specificity. Thus, above mentioned factors are fueling the segmental growth.
 

In terms of technology, microplates segment was worth USD 60 million in the year 2017 and is presumed to expand substantially during the estimated timeframe. The growth is attributed to advancements in microplates technology. Advanced microplates offer various benefits such as easy & quick washings for antiglobulin tests, reusability, and cost-effectiveness.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2506049/
 

Citing the end-use landscape, the report cites that Europe immunohematology market from blood banks segment will witness 1.7% CAGR during 2018-2024. Rising number of blood transfusions has enhanced the popularity of blood banks across the world. In addition, increasing awareness pertaining to blood donation is boosting the adoption of immunohematology across blood banks in Europe.
 

The prominent companies operating in Europe immunohematology market are Thermo Fisher Scientific, Siemens Healthcare, Roche Diagnostics, Immucor, Hologic, Grifols, Diagast, Bio-Rad Laboratories, Becton Dickinson, Beckman Coulter, ANTISEL S.A., and Abbott.


Frequently Asked Questions (FAQ) :

According to the report, Europe immunohematology market is expected to surpass USD 442 million by the year 2024. Factors such as increased pervasiveness of hematology disorders such as sickle-cell, thalassemia and leukemia are majorly driving the market growth. Thalassemia is a type of inherited blood ailment that lowers hemoglobin production. Patients suffering from such disorders require recurrent blood transfusions, thereby facilitating the Europe immunohematology market expansion. Advancements in technology pertaining to immunohematology analyzers are stimulating the industry outlook. These advanced systems are used in applications such as cross-matching, identification, donor antibody screening, phenotyping, antibody screening, and grouping. Thus, shifting focus towards R&D activities among key industry players to develop fully automated high-throughput devices is fostering the demand for the product across Europe.
The report states that reagents market segment held 65% share in the year 2017 is expected to register significant growth by the year 2024. Rising prevalence of hematological disorders have impelled the demand for recurring blood testing devices. Moreover, reagents are widely preferred in diagnostic centers owing to their high specificity. Thus, above mentioned factors are fueling the segmental growth.
Europe immunohematology market from blood banks segment will witness 1.7% CAGR during 2018-2024. Rising number of blood transfusions has enhanced the popularity of blood banks across the world. In addition, increasing awareness pertaining to blood donation is boosting the adoption of immunohematology across blood banks in Europe.
The prominent companies operating in Europe immunohematology market are Thermo Fisher Scientific, Siemens Healthcare, Roche Diagnostics, Immucor, Hologic, Grifols, Diagast, Bio-Rad Laboratories, Becton Dickinson, Beckman Coulter, ANTISEL S.A., and Abbott.